16th May 2024
FMD In | Focus May 2024
The latest issue of our newsletter is now available. Some of the topics include details of our new NMVS Alerts user guide for pharmacies and hospitals, an update on Brexit and the Windsor Framework, information about the latest release of the IMVS. Our colleague Ludvig Möller, Program & Alert Manager from the Swedish NMVO e-VIS,......READ MORE
19th December 2023
FMD In | Focus December 2023
The latest issue of our FMD | In Focus newsletter is now available. Some topics covered in this issue are the new HPRA Q&A on the Windsor Framework and information on the alert management webinars held for pharmacies and hospitals in November. The newsletter can be viewed here. If you want to subscribe to receive......READ MORE
26th October 2023
FMD In | Focus October 2023
The latest issue of our FMD | In Focus newsletter is now available. The topics covered in this issue are about the recent fake Ozempic packs that were identified in the legal supply in the UK and EU, an update on the Windsor Framework, a reminder to pharmacies and hospitals about lending and borrowing packs,......READ MORE
30th May 2022
FMD use and learn period ends in Ireland May 2022
The Falsified Medicines Directive (2011/62/EU) ‘(FMD’) introduced new requirements from February 2019 for safety features on prescription medicines packaging, enabling the packs to be authenticated as genuine prior to supply to patients. FMD has been in a ‘use and learn’ phase in Ireland since February 2019 due, in part, to the impact of Covid-19 and......READ MORE
31st January 2022
Important update about FMD and the end of use and learn
The Safety Features Oversight Group has agreed an updated timetable for the phased ending of the ‘use and learn’ period for FMD in Ireland. The new timings take account of the impact of the Omicron wave of Covid-19 and the decision before Christmas to defer phases 3 and 4 originally scheduled for 10th January. The......READ MORE
22nd December 2021
Important update about FMD and the end of use and learn
The next two phases of the end of use and learn plan for FMD that were scheduled to take effect on 10 January have been deferred until further notice, i.e., phase 3 (wholesalers to investigate alerts on returned packs) and phase 4 (red/amber/green colours switched on in FMD software for pharmacies and hospitals). See table......READ MORE
09th July 2021
FMD use and learn period due to end in Ireland in Q1 2022
Note that the update to the end of use and learn plan supersedes the details of this post. Please click here for this update. The Safety Features Oversight Group[1] continues to oversee progress with FMD implementation in Ireland. FMD has been in a ‘use and learn’ phase for pharmacies, hospitals and wholesalers in this country......READ MORE
23rd June 2021
IMVO launches Corporate Strategy 2021-2023 focusing on operational excellence
The IMVO Board has recently signed off IMVO’s first Corporate Strategy covering the period 2021-2023. Since 2017, IMVO has prioritised meeting our obligations to set up the Irish Medicines Verification System (IMVS) and connecting over 2000 pharmacies, hospitals and wholesalers, as well as onboarding over 300 marketing authorisation holders whose pack data is hosted in......READ MORE
31st March 2021
Falsified Medicine Directive aiding pharmacy management
New IMVO survey shows one in four pharmacies say FMD software is making a difference Assisting with expiry date tracking among other reports IMVO has launched a new website to support pharmacists and other system users Medicines scanning under the Falsified Medicines Directive (FMD) is making a positive difference to pharmacy management, according to a......READ MORE
01st December 2020
FMD Use and Learn Period in Ireland to continue into 2021
The Safety Features Oversight Group (comprising IMVO, HPRA, PSI, Department of Health, HSE and Private Hospitals Association) continues to oversee progress with FMD implementation in Ireland. Because of the unique circumstances in which we find ourselves this year and the need to ensure that the medicines supply chain can cope with whatever challenges the Covid-19......READ MORE
